Thursday, January 26, 2017 7:57:49 PM
Shefa Amirim provides clients with the requisite regulatory plans, designing and conducting the required clinical studies, CRO services and the preparation of technical files and and related services necessary for FDA applications and approval.
Now, think bigger then our psoriasis Cream...
The company stated recently, "We will submitt an application with the FDA for an orphan disease application for multiple Myeloma."
This could becoming up sooner then we think with Shefa coming on board!
Now look at for example GWPH's stock once they got close too orphan disease approval last March, April time frame of there epilepsy drug. It about doubled from about $20.00 to $40.00 and the rest was history.
Im not sure when, but someday soon this stock will gap up and never look back! IMO
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM